Tafero
Tafero contains Tenofovir Alafenamide (25mg), which is a hepatitis B virus (HBV) nucleoside analog reverse transcriptase inhibitor. It helps reduce the amount of hepatitis B virus in the body, which can prevent liver damage, cirrhosis, and liver cancer.
Dosage by Body Weight
The standard adult and adolescent (aged 12 years and older, weighing at least 35 kg) dosage is one 25 mg tablet orally once daily with food.
- Body Weight
- Below 5 kg
- Dose
- Not recommended
- Frequency
- Not applicable
- Tracking Notes
- Safety and efficacy have not been established in patients weighing less than 35 kg.
- Body Weight
- 5-7 kg
- Dose
- Not recommended
- Frequency
- Not applicable
- Tracking Notes
- Safety and efficacy have not been established in patients weighing less than 35 kg.
- Body Weight
- 8-10 kg
- Dose
- Not recommended
- Frequency
- Not applicable
- Tracking Notes
- Safety and efficacy have not been established in patients weighing less than 35 kg.
- Body Weight
- 11-15 kg
- Dose
- Not recommended
- Frequency
- Not applicable
- Tracking Notes
- Safety and efficacy have not been established in patients weighing less than 35 kg.
- Body Weight
- 16-20 kg
- Dose
- Not recommended
- Frequency
- Not applicable
- Tracking Notes
- Safety and efficacy have not been established in patients weighing less than 35 kg.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Not recommended | Not applicable | Safety and efficacy have not been established in patients weighing less than 35 kg. |
| 5-7 kg | Not recommended | Not applicable | Safety and efficacy have not been established in patients weighing less than 35 kg. |
| 8-10 kg | Not recommended | Not applicable | Safety and efficacy have not been established in patients weighing less than 35 kg. |
| 11-15 kg | Not recommended | Not applicable | Safety and efficacy have not been established in patients weighing less than 35 kg. |
| 16-20 kg | Not recommended | Not applicable | Safety and efficacy have not been established in patients weighing less than 35 kg. |
Formulation
Tablet
Purpose
Treatment of chronic hepatitis B virus (HBV) infection in adults and adolescents with compensated liver disease, and as part of combination antiretroviral therapy for HIV-1 infection.
Generic Name
Tenofovir AlafenamideScheduled Drug
Yes. This medicine should be supplied or used only according to applicable prescription and regulatory requirements.